Mounting Evidence Supports Sirolimus To Treat Capillary Lymphatic Venous Malformations
New data support the growing consensus on the effectiveness and safety of sirolimus in managing complex vascular anomalies.
Related Articles
AI versus AI: The emerging arms race over health insurance denials
As health insurers use AI to deny more claims, startups are turning to AI to make it easier to appeal denials, which often go uncontested.
Inequalities in uptake of childhood vaccination in England, 2019-23: longitudinal study
Objective To quantify changes in inequalities in uptake of childhood vaccination during a period of steadily declining overall childhood vaccination rates in England. Design Longitudinal…
The Hidden Dangers of AI Confidence Scores in Healthcare – MedCity News
AI can serve as an invaluable tool, but blindly trusting “confidence scores” creates serious risks. Here are some better alternatives.
Health-care workers are under attack. We must do more to ensure their safety – Healthy Debate
Every day health-care workers experience a spectrum of abusive behaviour while providing care. More needs to be done to stop it.
Europe allows Novo to include reduction of kidney disease in Ozempic label
The European Medicines Agency (EMA) will allow Novo Nordisk to add risk reduction for events related to kidney disease to the label of its diabetes…
OpenAI partners with defense contractor Anduril for drone defense systems
OpenAI enters into a partnership in the defense sector for the first time. The ChatGPT developer wants to develop AI systems for drone defense with…
Buprenorphine prescribing practices for older adults in 2019 and 2020
Background Opioid use disorder (OUD) prevalence has increased threefold among Medicare beneficiaries 65 years and older (hereafter “older adults”) since 2013, with a prevalence of 15.7…
Can We Shorten the Duration of Antibiotic Treatment for Bacteremia?
Traditionally, non–Staphylococcus aureus bacteremic infections have been most commonly managed with 14 days of intravenous antibiotic therapy. But
Vraylar sales growth seen slowing in 2025, says Richter CEO
Hungarian pharmaceutical company Richter expects a slowdown in sales growth for its flagship product, Vraylar, next year while supply chain disruptions continue to pose challenges,…
Krispy Kreme orders across the US disrupted after cyberattack
Wider details about the hole truth are still unknown